European CE Marking of Medical Devices. October 2017

Size: px
Start display at page:

Download "European CE Marking of Medical Devices. October 2017"

Transcription

1 European CE Marking of Medical Devices October

2 2017 EU Regulations Why? Response to scandals to restore confidence in system Keep pace with scientific and technical developments Overcome divergence in interpretation and application 2

3 1. Better protection of public health and patient safety Strict pre-market control Inclusion of certain aesthetic devices Reinforced designation and oversight of Notified Bodies Reinforced rules on clinical / performance evaluation and clinical investigation / performance studies Strict rules for substance-based devices Strict rules for use of hazardous substances Introduction of UDI 3

4 1. Better protection of public health and patient safety Strict pre-market control Inclusion of certain aesthetic devices Reinforced designation and oversight of Notified Bodies Reinforced rules on clinical / performance evaluation and clinical investigation / performance studies Strict rules for substance-based devices Strict rules for use of hazardous substances Introduction of UDI 4

5 Total - AIMD, MD, IVD Audit Days 2017 EU Regulations Impact 1. Better protection of public health and patient safety Strict pre-market control Inclusion of certain aesthetic devices Reinforced designation and oversight of Notified Bodies Reinforced rules on clinical / performance evaluation and clinical investigation / performance studies Strict rules for substance-based devices Strict rules for use of hazardous substances Introduction of UDI MHRA - Witnessed & Surveillance Medical Devices Notified Bodies

6 1. Better protection of public health and patient safety Strict pre-market control Inclusion of certain aesthetic devices Reinforced designation and oversight of Notified Bodies Reinforced rules on clinical / performance evaluation and clinical investigation / performance studies Strict rules for substance-based devices Strict rules for use of hazardous substances Introduction of UDI 6

7 1. Better protection of public health and patient safety Strict pre-market control Inclusion of certain aesthetic devices Reinforced designation and oversight of Notified Bodies Reinforced rules on clinical / performance evaluation and clinical investigation / performance studies Strict rules for substance-based devices Strict rules for use of hazardous substances Introduction of UDI 7

8 1. Better protection of public health and patient safety Strict pre-market control Inclusion of certain aesthetic devices Reinforced designation and oversight of Notified Bodies Reinforced rules on clinical / performance evaluation and clinical investigation / performance studies Strict rules for substance-based devices Strict rules for use of hazardous substances Introduction of UDI MDR, Annex I, SPR#10.4 8

9 1. Better protection of public health and patient safety Strict pre-market control Inclusion of certain aesthetic devices Reinforced designation and oversight of Notified Bodies Reinforced rules on clinical / performance evaluation and clinical investigation / performance studies Strict rules for substance-based devices Strict rules for use of hazardous substances Introduction of UDI 9

10 2. Legal certainty and innovation-friendly environment Use of regulation as a regulatory tool Clarification of scope for both MD and IVDs Stronger role for the Commission on the regulatory status of products Clarification of regime applicable to devices manufactured and used in the same healthcare institution Clarification of responsibilities of economic operators New rules for software / apps 10

11 2. Legal certainty and innovation-friendly environment Use of regulation as a regulatory tool Clarification of scope for both MD and IVDs Stronger role for the Commission on the regulatory status of products Clarification of regime applicable to devices manufactured and used in the same healthcare institution Clarification of responsibilities of economic operators New rules for software / apps JRC Expert Panels 11

12 2. Legal certainty and innovation-friendly environment Use of regulation as a regulatory tool Clarification of scope for both MD and IVDs Stronger role for the Commission on the regulatory status of products Clarification of regime applicable to devices manufactured and used in the same healthcare institution Clarification of responsibilities of economic operators New rules for software / apps 12

13 2. Legal certainty and innovation-friendly environment Use of regulation as a regulatory tool Clarification of scope for both MD and IVDs Stronger role for the Commission on the regulatory status of products Clarification of regime applicable to devices manufactured and used in the same healthcare institution Clarification of responsibilities of economic operators New rules for software / apps 13

14 3. Increase transparency and patient empowerment Establishment of EU database on medical devices (EUDAMED) with a large part to be made publicly available Introduction of an implant card to be provided to patients Summary of safety and performance for all Class III and implantable devices available in EUDAMED New obligations for manufacturers and authorised representatives aimed at protecting consumers/patients 14

15 3. Increase transparency and patient empowerment Establishment of EU database on medical devices (EUDAMED) with a large part to be made publicly available Introduction of an implant card to be provided to patients Summary of safety and performance for all Class III and implantable devices available in EUDAMED New obligations for manufacturers and authorised representatives aimed at protecting consumers/patients 15

16 3. Increase transparency and patient empowerment Establishment of EU database on medical devices (EUDAMED) with a large part to be made publicly available Introduction of an implant card to be provided to patients Summary of safety and performance for all Class III and implantable devices available in EUDAMED New obligations for manufacturers and authorised representatives aimed at protecting consumers/patients device name serial number lot number Unique Device Identification device model manufacturer name, address and website any warnings, precautions or measures to be taken by the patient or a healthcare professional with regard to reciprocal interference with reasonably foreseeable external influences, medical examinations or environmental conditions; any information about the expected lifetime of the device and any necessary follow-up; any other information to assure a safe use of the device by the patient including the information in point (u) Annex I, Section 23.4 Instructions for Use 16

17 4. European approach Registration of devices and economic operators Improved coordination between Member States in the fields of vigilance and market surveillance Strengthening EU Joint Assessment procedure for Notified Bodies Coordinated assessment of clinical investigations conducted in more than one Member State 17

18 Requirements EU Regulations Clinical Oversight Joint Assessments Unannounced Audits Interim Regulations & Recommendations Future Regulation 2017 Time 18

19 BSI Medical Devices 19

20 EU MDR / IVDR Designation Article / November

21 EU MDR / IVDR Designation Article / November

22 NBOG Codes Notified Body Designation Orthopaedic Dental Active Implantable Devices Active Devices IVDs MDR n=70 IVDR n=85 Vascular General Devices Biological Substances Drug-Device Combination 22 16/10/2017

23 Designation Pilot Audits Volunteers required Quality System Audits Unannounced Audits Microbiology & Sterilisation Audits Class I Reusable Technical Documentation Reviews 23

24 Webinars Whitepapers Roadshows 24

25 25

26 Questions Thank You! 26

New EU legislation on Medical Devices. Erik Hansson Deputy Head of Unit European Commission DG Health and Consumers 1

New EU legislation on Medical Devices. Erik Hansson Deputy Head of Unit European Commission DG Health and Consumers 1 New EU legislation on Medical Devices Erik Hansson Deputy Head of Unit European Commission DG Health and Consumers 1 Drivers for change Presentation Commission proposals State of play in negotiations What

More information

European IVD Regulations and Risk Based Classification. An Overview for Global Quality Professionals

European IVD Regulations and Risk Based Classification. An Overview for Global Quality Professionals European IVD Regulations and Risk Based Classification An Overview for Global Quality Professionals Anna Sadio IVD Technical Expert/Project Manager Oct 2013 Caution The new regulations are draft and subject

More information

EPF recommendations for the trilogue on the proposal for regulation on Medical Devices

EPF recommendations for the trilogue on the proposal for regulation on Medical Devices EPF recommendations for the trilogue on the proposal for regulation on Medical Devices Contents 1. Introduction... 3 2. EPF recommendations for the trilogue... 3 2.1 Gaps in Patient safety and quality

More information

EUROPEAN PARLIAMENT Committee on the Environment, Public Health and Food Safety

EUROPEAN PARLIAMENT Committee on the Environment, Public Health and Food Safety EUROPEAN PARLIAMT 2009-2014 Committee on the Environment, Public Health and Food Safety 2012/0266(COD) 12.4.2013 ***I DRAFT REPORT on the proposal for a regulation of the European Parliament and of the

More information

Medical devices briefing for patients: Patient safety in the new Regulation

Medical devices briefing for patients: Patient safety in the new Regulation Medical devices briefing for patients: Patient safety in the new Regulation 20/12/2016 Patient safety is an important priority for the European Patients Forum, and it was also our main priority in our

More information

EUROPEAN PARLIAMENT Plenary sitting

EUROPEAN PARLIAMENT Plenary sitting EUROPEAN PARLIAMT 2009-2014 Plenary sitting A7-0324/2013 9.10.2013 ***I REPORT on the proposal for a regulation of the European Parliament and of the Council on medical devices, and amending Directive

More information

European Commission s proposal for a Regulation on Medical Devices (2012/0266 (COD)) EPF Position Statement

European Commission s proposal for a Regulation on Medical Devices (2012/0266 (COD)) EPF Position Statement European Commission s proposal for a Regulation on Medical Devices (2012/0266 (COD)) EPF Position Statement April 2013 Introduction: Medical devices include any apparatus, appliance, software, material

More information

Secretary-General of the European Commission, signed by Mr Jordi AYET PUIGARNAU, Director

Secretary-General of the European Commission, signed by Mr Jordi AYET PUIGARNAU, Director COUNCIL OF THE EUROPEAN UNION Brussels, 17 June 2014 (OR. en) 10343/14 COVER NOTE From: date of receipt: 16 June 2014 To: No. Cion doc.: Subject: PHARM 41 SAN 219 MI 465 COMPET 308 CODEC 1382 Secretary-General

More information

Changes in the Medical Device Legislation; the day after. Jan Bart Hak 1

Changes in the Medical Device Legislation; the day after. Jan Bart Hak 1 PPN Najaarsbijeenkomst 21 November 2017 Changes in the Medical Device Legislation; the day after. How much time do we have left? Jan Bart Hak Jan Bart Hak 1 Company Leading consultancy and project management

More information

IVDD revision changes to the European regulation of in-vitro diagnostic (IVD) Medical Devices. Med-Info. TÜV SÜD Product Service GmbH

IVDD revision changes to the European regulation of in-vitro diagnostic (IVD) Medical Devices. Med-Info. TÜV SÜD Product Service GmbH Med-Info International expert information for the Medical Device industry IVDD revision changes to the European regulation of in-vitro diagnostic (IVD) Medical Devices The current regulatory framework

More information

Brussels, 12 June 2014 COUNCIL OF THE EUROPEAN UNION 10855/14. Interinstitutional File: 2012/0266 (COD) 2012/0267 (COD)

Brussels, 12 June 2014 COUNCIL OF THE EUROPEAN UNION 10855/14. Interinstitutional File: 2012/0266 (COD) 2012/0267 (COD) COUNCIL OF THE EUROPEAN UNION Brussels, 12 June 2014 Interinstitutional File: 2012/0266 (COD) 2012/0267 (COD) 10855/14 PHARM 44 SAN 232 MI 492 COMPET 405 CODEC 1471 NOTE from: General Secretariat of the

More information

MHRA response to the Independent Review on access to clinical advice and engagement with the clinical community in relation to medical devices

MHRA response to the Independent Review on access to clinical advice and engagement with the clinical community in relation to medical devices MHRA response to the Independent Review on access to clinical advice and engagement with the clinical community in relation to medical devices The MHRA warmly welcomes the independent report Expert Clinical

More information

IAF Mandatory Document for the Application of ISO/IEC in Medical Device Quality Management Systems (ISO 13485)

IAF Mandatory Document for the Application of ISO/IEC in Medical Device Quality Management Systems (ISO 13485) IAF MD 8:2011. International Accreditation Forum, Inc.(IAF) IAF Mandatory Document IAF Mandatory Document for the Application of ISO/IEC 17011 in Medical Device Quality Management Systems (ISO (IAF MD

More information

The New EU PV Legislation: View from the European Commission

The New EU PV Legislation: View from the European Commission The New EU PV Legislation: View from the European Commission International seminar 26 May 2011 Lenita LINDSTRÖM Senior Policy Officer Pharmaceuticals Unit/DG SANCO Rationale for the revision Calls for

More information

Post Market Surveillance Requirements. SAMED Regulatory Conference 2 December 2015

Post Market Surveillance Requirements. SAMED Regulatory Conference 2 December 2015 Post Market Surveillance Requirements SAMED Regulatory Conference 2 December 2015 Topics Surveillance & Vigilance Adverse Events Reportable Adverse Events Reporting Adverse Events Time frames Exemptions

More information

Raad voor Accreditatie (Dutch Accreditation Council RvA) Specific Accreditation Protocol for Certification according to ISO/IEC 13485

Raad voor Accreditatie (Dutch Accreditation Council RvA) Specific Accreditation Protocol for Certification according to ISO/IEC 13485 Raad voor Accreditatie (Dutch Accreditation Council RvA) Specific Accreditation Protocol for Certification according to ISO/IEC 13485 Document code: RvA-SAP-C021-UK Version 2, 6-6-2017 A Specif ic Accreditation

More information

ASSESSMENT OF THE CONSOLIDATED ANNUAL ACTIVITY REPORT OF THE AUTHORISING OFFICER FOR THE YEAR 2014

ASSESSMENT OF THE CONSOLIDATED ANNUAL ACTIVITY REPORT OF THE AUTHORISING OFFICER FOR THE YEAR 2014 Management Board Decision 07/2015 1(5) ASSESSMENT OF THE CONSOLIDATED ANNUAL ACTIVITY REPORT OF THE AUTHORISING OFFICER FOR THE YEAR 2014 THE MANAGEMENT BOARD, Having regard to Regulation (EC) No 1907/2006

More information

DRAFT OPINION. EN United in diversity EN. European Parliament 2018/0018(COD) of the Committee on Industry, Research and Energy

DRAFT OPINION. EN United in diversity EN. European Parliament 2018/0018(COD) of the Committee on Industry, Research and Energy European Parliament 2014-2019 Committee on Industry, Research and Energy 2018/0018(COD) 13.4.2018 DRAFT OPINION of the Committee on Industry, Research and Energy for the Committee on the Environment, Public

More information

GUIDELINES ON A MEDICAL DEVICES VIGILANCE SYSTEM

GUIDELINES ON A MEDICAL DEVICES VIGILANCE SYSTEM EUROPEAN COMMISSION DG ENTERPRISE AND INDUSTRY Directorate F-Consumer Good Unit F3- Cosmetic and Medical Devices MEDICAL DEVICES: Guidance document MEDDEV 2.12-1 rev 6 December 2009 GUIDELINES ON A MEDICAL

More information

EUCERD RECOMMENDATIONS QUALITY CRITERIA FOR CENTRES OF EXPERTISE FOR RARE DISEASES IN MEMBER STATES

EUCERD RECOMMENDATIONS QUALITY CRITERIA FOR CENTRES OF EXPERTISE FOR RARE DISEASES IN MEMBER STATES EUCERD RECOMMENDATIONS QUALITY CRITERIA FOR CENTRES OF EXPERTISE FOR RARE DISEASES IN MEMBER STATES 24 OCTOBER 2011 INTRODUCTION 1. THE EUROPEAN CONTEXT Centres of expertise (CE) and European Reference

More information

COMMISSION IMPLEMENTING REGULATION (EU)

COMMISSION IMPLEMENTING REGULATION (EU) L 253/8 Official Journal of the European Union 25.9.2013 COMMISSION IMPLEMENTING REGULATION (EU) No 920/2013 of 24 September 2013 on the designation and the supervision of notified bodies under Council

More information

FINAL STATUS DOCUMENT

FINAL STATUS DOCUMENT GHTF/SG2/N68R3: 2005 FINAL STATUS DOCUMENT Global Harmonization Task Force Title: Summary of Current Requirements for Where to Send Adverse Event Reports. Authoring Group: GHTF Study Group 2 Endorsed by:

More information

Fundamentals in Regulatory Affairs for Medical Technologies

Fundamentals in Regulatory Affairs for Medical Technologies Fundamentals in Regulatory Affairs for Medical Technologies Developed by Industry for Industry NFQ Level 8 9 ects The Irish Medtech Skillnet is funded by member companies and the Training Networks Programme,

More information

Improving joint replacement

Improving joint replacement Improving joint replacement The National Joint Registry for England, Wales and Northern Ireland nts surgeons nhs hospitals independent sector healthcare profe ctors nurses regulators commissioners implant

More information

Guide to Incident Reporting for General Medical Devices and Active Implantable Medical Devices

Guide to Incident Reporting for General Medical Devices and Active Implantable Medical Devices Guide to Incident Reporting for General Medical Devices and Active Implantable Medical Devices SUR-G0003-4 09 JULY 2012 This guide does not purport to be an interpretation of law and/or regulations and

More information

Presented to Parliament by the Secretary of State for Health and Social Care by Command of Her Majesty. May Cm 9620

Presented to Parliament by the Secretary of State for Health and Social Care by Command of Her Majesty. May Cm 9620 Brexit: medicines, medical devices and substances of human origin: Government response to the Health and Social Care Committee's Fourth Report of Session 2017-19 Cm 9620 Brexit: medicines, medical devices

More information

Therefore the provision of medicines is an area for which a Community regulatory framework should be properly supervised to ensure full and

Therefore the provision of medicines is an area for which a Community regulatory framework should be properly supervised to ensure full and European Association of Pharmaceutical Full-line Wholesalers (GIRP) response to the European Commission Consultation regarding Community action on Health Services Introduction Firstly, GIRP welcomes the

More information

Fundamentals in Regulatory Affairs for Medical Technologies

Fundamentals in Regulatory Affairs for Medical Technologies Fundamentals in Regulatory Affairs for Medical Technologies Developed by Industry for Industry NFQ Level 8 (approval pending) The IMDA Skillnet is funded by member companies and the Training Networks Programme,

More information

Guide to Incident Reporting for In-vitro Diagnostic Medical Devices

Guide to Incident Reporting for In-vitro Diagnostic Medical Devices Guide to Incident Reporting for In-vitro Diagnostic Medical Devices SUR-G0004-4 02 AUGUST 2012 This guide does not purport to be an interpretation of law and/or regulations and is for guidance purposes

More information

9/10/2013. Contributions of ECHA to the achievement of the REACH goals. Content of Discussion

9/10/2013. Contributions of ECHA to the achievement of the REACH goals. Content of Discussion Contributions of ECHA to the achievement of the REACH goals 5 Jahre REACH und weitere Beitrage zur Nachhaltigen Chemie Darmstadt, Germany 4 September 2013 Geert Dancet Executive Director Content of Discussion

More information

Re: Docket No. FDA 2013-N-0500 Proposed Rule: Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products

Re: Docket No. FDA 2013-N-0500 Proposed Rule: Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products March 13, 2014 BY ELECTRONIC DELIVERY Dockets Management Branch (HFA-305) Food and Drug Administration 5630 Fishers Lane, Rm. 1061 Rockville, MD 20852 Re: Docket No. FDA 2013-N-0500 Proposed Rule: Supplemental

More information

Safety Surveillance for Medical Devices

Safety Surveillance for Medical Devices Safety Surveillance for Medical Devices May 10, 2012 James P. Keller, M.S. Vice President, Health Technology Evaluation and Safety jkeller@ecri.org (610) 825-6000, ext. 5279 Presentation Overview ECRI

More information

Official Journal of the European Union. (Non-legislative acts) REGULATIONS

Official Journal of the European Union. (Non-legislative acts) REGULATIONS 4.1.2017 L 1/1 II (Non-legislative acts) REGULATIONS COMMISSION IMPLEMTING REGULATION (EU) 2017/1 of 3 January 2017 on procedures for watercraft identification under Directive 2013/53/EU of the European

More information

MSc REGULATORY AFFAIRS MEDICINES / MEDICAL DEVICES PROSPECTUS

MSc REGULATORY AFFAIRS MEDICINES / MEDICAL DEVICES PROSPECTUS MSc REGULATORY AFFAIRS MEDICINES / MEDICAL DEVICES PROSPECTUS ABOUT THE MSc ABOUT US The Organisation for Professionals in Regulatory Affairs has been running the TOPRA MSc Regulatory Affairs more than

More information

UPDATE: Regulatory Framework for Medical Devices in South Africa. SAMED Annual Conference. 14 June 2018 Jerry Molokwane

UPDATE: Regulatory Framework for Medical Devices in South Africa. SAMED Annual Conference. 14 June 2018 Jerry Molokwane UPDATE: Regulatory Framework for Medical Devices in South Africa SAMED Annual Conference 14 June 2018 Jerry Molokwane Medicines and Related Substances Act, 1965 (Act 101 of 1965) Act 72 of 2008 and Act

More information

Safeguarding public health. The New PV Legislation. Perspective from a Member State

Safeguarding public health. The New PV Legislation. Perspective from a Member State Safeguarding public health The New PV Legislation Perspective from a Member State Mick Foy Reinforcing patient safety in Europe, Zagreb June 2011 Content Background The new EU PV Package ADR Definition

More information

Name of Researcher: Professor Kimme Hyrich. PARTICIPANT INFORMATION SHEET Version 8.0; 19 th October 2016

Name of Researcher: Professor Kimme Hyrich. PARTICIPANT INFORMATION SHEET Version 8.0; 19 th October 2016 Hospital Letterhead Paper Title of Project: Are new treatments for rheumatic conditions harmful to long term health? (British Society for Rheumatology Biologics Register for Rheumatoid Arthritis, BSRBR-RA)

More information

Quality Risk Management ICH Q9

Quality Risk Management ICH Q9 Quality Risk Management ICH Q9 Executive summary for competent authorities and industry Disclaimer: This presentation includes the author s views on quality risk management theory and practice. The presentation

More information

IVD Regulatory Update February 2015

IVD Regulatory Update February 2015 IVD Regulatory Update February 2015 Sue Spencer Head of IVD Notified Body Copyright 2015 BSI. All rights reserved. Content IVD proposals Expected timelines Impacts: Re-classification Clinical evidence

More information

Medical Devices and Device-Led Combination Products; Voluntary Malfunction Summary

Medical Devices and Device-Led Combination Products; Voluntary Malfunction Summary This document is scheduled to be published in the Federal Register on 08/17/2018 and available online at https://federalregister.gov/d/2018-17770, and on govinfo.gov 4164-01-P DEPARTMENT OF HEALTH AND

More information

Procedure for handling applications for authorisation and review reports under REACH

Procedure for handling applications for authorisation and review reports under REACH Procedure for handling applications for authorisation and review reports under REACH 1. Purpose This procedure describes how to handle applications for authorisation (AfA) as established by the REACH Regulation

More information

Development of a draft five-year global strategic plan to improve public health preparedness and response

Development of a draft five-year global strategic plan to improve public health preparedness and response Information document 1 August 2017 Development of a draft five-year global strategic plan to improve public health preparedness and response Consultation with Member States SUMMARY 1. This document has

More information

GUIDELINES ON MEDICAL DEVICES CLINICAL INVESTIGATIONS: SERIOUS ADVERSE EVENT REPORTING

GUIDELINES ON MEDICAL DEVICES CLINICAL INVESTIGATIONS: SERIOUS ADVERSE EVENT REPORTING EUROPEAN COMMISSION DIRECTORATE GENERAL for HEALTH and CONSUMERS Consumer Affairs Cosmetics and Medical Devices MEDDEV 2.7/3 December 2010 GUIDELINES ON MEDICAL DEVICES CLINICAL INVESTIGATIONS: SERIOUS

More information

Questions and answers about Recycling Processes

Questions and answers about Recycling Processes Questions and answers about Recycling Processes 1. How do I apply for an authorisation for a plastic recycling process? 1. You should draw up an application following the European Food Safety Authority

More information

NOTE BY THE TECHNICAL SECRETARIAT

NOTE BY THE TECHNICAL SECRETARIAT OPCW Technical Secretariat International Cooperation and Assistance Division S/551/2006 27 February 2006 Original: ENGLISH Introduction NOTE BY THE TECHNICAL SECRETARIAT INVITATION TO NATIONAL AUTHORITIES

More information

INVOLVING PATIENTS IN PHARMACOVIGILANCE EPF TOOLKIT. Susanna Palkonen, EPF Board Member

INVOLVING PATIENTS IN PHARMACOVIGILANCE EPF TOOLKIT. Susanna Palkonen, EPF Board Member INVOLVING PATIENTS IN PHARMACOVIGILANCE EPF TOOLKIT Susanna Palkonen, EPF Board Member EPF About us Independent, non-governmental umbrella organisation set up in 2003 VISION: High-quality, patientcentred,

More information

Australian Standard. Clinical investigations of medical devices for human subjects. Part 1: General requirements AS ISO ISO :2003

Australian Standard. Clinical investigations of medical devices for human subjects. Part 1: General requirements AS ISO ISO :2003 AS ISO 14155.1 2004 ISO 14155-1:2003 AS ISO 14155.1 2004 Australian Standard Clinical investigations of medical devices for human subjects Part 1: General requirements This Australian Standard was prepared

More information

FDA s Office of Regulatory Affairs: Violation Trends & Medical Device Update

FDA s Office of Regulatory Affairs: Violation Trends & Medical Device Update FDA s Office of Regulatory Affairs: Violation Trends & Medical Device Update Ginger M. Sykes Supervisory Consumer Safety Officer Salt Lake City Resident Post Office of Regulatory Affairs U.S. Food and

More information

Medical Device and Health Software

Medical Device and Health Software Medical Device and Health Software Standards and regulations now and in the future Justin McCarthy Introduction I was head of Clinical Engineering in Cardiff till 2009. I have been chair of BSI committee

More information

Policies Approved by the 2017 ASHP House of Delegates

Policies Approved by the 2017 ASHP House of Delegates House of Delegates Policies Approved by the 2017 ASHP House of Delegates 1701 Ensuring Patient Safety and Data Integrity During Cyber-attacks Source: Council on Pharmacy Management To advocate that healthcare

More information

November Innovative Medicines Initiative (IMI) Intellectual Property (IP) Policy. Guidance Note for IMI Applicants and Participants

November Innovative Medicines Initiative (IMI) Intellectual Property (IP) Policy. Guidance Note for IMI Applicants and Participants Innovative Medicines Initiative (IMI) Intellectual Property (IP) Policy Guidance Note for IMI Applicants and Participants 1. INTRODUCTION The purpose of this guidance note 1 is: - to clarify the IMI IP

More information

- Proposal for a Regulation on HTA- Ioana Siska, MD, PhD DG SANTE - Health Systems and Products Medical Products: safety, quality, innovation

- Proposal for a Regulation on HTA- Ioana Siska, MD, PhD DG SANTE - Health Systems and Products Medical Products: safety, quality, innovation - Proposal for a Regulation on HTA- Ioana Siska, MD, PhD DG SANTE - Health Systems and Products Medical Products: safety, quality, innovation Pharma Committee meeting, 8 March 2018 Background More than

More information

Annual Work Programme 2018

Annual Work Programme 2018 Annual Work Programme 2018 Infoday 30 January 2018 Irène ATHANASSOUDIS DG SANTE C1 The Health Programme Regulation EU N 282/2014 of 11 March 2014 Promoting health Encouraging innovation in health Complement,

More information

Health and Safety Authority. Function and Scope of REACH and CLP Helpdesks

Health and Safety Authority. Function and Scope of REACH and CLP Helpdesks Rev 1. June 2009 Health and Safety Authority Function and Scope of REACH and CLP Helpdesks Introduction The EU Regulation for Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH)

More information

ECHA and the implementation of REACH,CLP and other tasks

ECHA and the implementation of REACH,CLP and other tasks ECHA and the implementation of REACH,CLP and other tasks Eva Sandberg International Unit www.kemi.se ECHA, its tasks and organisation European Chemicals Agency ECHA REACH Regulation entered into force

More information

Communication & Dissemination in FP7 projects. Stéphane Hogan Head of Unit Horizontal Aspects and Coordination Health Directorate DG Research

Communication & Dissemination in FP7 projects. Stéphane Hogan Head of Unit Horizontal Aspects and Coordination Health Directorate DG Research Communication & Dissemination in FP7 projects Stéphane Hogan Head of Unit Horizontal Aspects and Coordination Health Directorate DG Research Information 1 meeting 4 May 2009 2 Dissemination is an obligation

More information

Australian Canoeing Limited Workplace Health & Safety Policy

Australian Canoeing Limited Workplace Health & Safety Policy Australian Canoeing Limited Workplace Health & Safety Policy Date adopted by the Board 8 th May 2016 Date effective 8 th May 2016 Australian Canoeing PO Box 6805 Silverwater, NSW 2128 T: (02) 9763 0670

More information

Guidance on the Biocidal Products Regulation

Guidance on the Biocidal Products Regulation G U I D A N C E Guidance on the Biocidal Products Regulation Volume V, Guidance on active substances and suppliers (Article list) Draft Version.0 September 0 DRAFT Volume V: Guidance on active substances

More information

Process and methods Published: 23 January 2017 nice.org.uk/process/pmg31

Process and methods Published: 23 January 2017 nice.org.uk/process/pmg31 Evidence summaries: process guide Process and methods Published: 23 January 2017 nice.org.uk/process/pmg31 NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).

More information

NBOG Report for the period

NBOG Report for the period NBOG Report for the period 2005 2008 1 Introduction...2 2 Background...2 3 Work Programme, Activities, Achievements...2 3.1 Overview...2 3.2 Guidance documents...3 3.3 Review of NB-MED Recommendations...6

More information

XL Foods Inc. Independent Review Recommendations and Government Action Plan

XL Foods Inc. Independent Review Recommendations and Government Action Plan XL Foods Inc. Independent Review Recommendations and Government Action Plan Recommendations 1. A strong food safety culture must be developed within the processing plant, and adopted by both plant and

More information

San Francisco General Hospital INFECTION CONTROL

San Francisco General Hospital INFECTION CONTROL San Francisco General Hospital INFECTION CONTROL SCOPE OF SERVICE 2009 The Infection Control Program at San Francisco General Hospital is a comprehensive quality improvement function that serves patients,

More information

EUROPEAN COMMISSION INFORMATION SOCIETY AND MEDIA DG INTERNATIONAL COOPERATION PUBLIC CONSULTATION FIRST OVERVIEW

EUROPEAN COMMISSION INFORMATION SOCIETY AND MEDIA DG INTERNATIONAL COOPERATION PUBLIC CONSULTATION FIRST OVERVIEW EUROPEAN COMMISSION INFORMATION SOCIETY AND MEDIA DG INTERNATIONAL COOPERATION PUBLIC CONSULTATION FIRST OVERVIEW Global Forum Venice 5-6 November JF SOUPIZET HEAD OF INTERNATIONAL RELATIONS DG INFSO These

More information

Post- Fukushima accident. Action plan. Follow-up of the peer review of the stress tests performed on European nuclear power plants

Post- Fukushima accident. Action plan. Follow-up of the peer review of the stress tests performed on European nuclear power plants Post- Fukushima accident Action plan Follow-up of the peer review of the stress tests performed on European nuclear power plants Action Plan Follow-up of the peer review of the stress tests performed on

More information

CAPACITIES WORK PROGRAMME (European Commission C(2009)5905 of 29 July 2009)

CAPACITIES WORK PROGRAMME (European Commission C(2009)5905 of 29 July 2009) WORK PROGRAMME 2010 1 CAPACITIES (European Commission C(2009)5905 of 29 July 2009) 1 In accordance with Articles 163 to 173 of the EC Treaty, and in particular Article 166(1) as contextualised in the following

More information

Role Profile Medical Officer- Medical Devices

Role Profile Medical Officer- Medical Devices Role Profile Medical Officer- Medical Devices ROLE SUMMARY The Medical Officer role will be within the Medical Devices department. Reporting to the Deputy Director Medical Devices, the role of the Medical

More information

3rd Health Programme

3rd Health Programme 3rd Health Programme 2014-2020 Joint Action to strengthen preparedness in the EU against serious cross-border threats to health and support the implementation of the International Health Regulations Luxembourg,

More information

INFORMATION TO BE GIVEN

INFORMATION TO BE GIVEN (To be filled out in the EDPS' office) REGISTER NUMBER: 1385 (To be filled out in the EDPS' office) NOTIFICATION FOR PRIOR CHECKING DATE OF SUBMISSION: 29/07/2016 CASE NUMBER: 2016-0695 INSTITUTION: ECB

More information

Guidance on the Biocidal Products Regulation

Guidance on the Biocidal Products Regulation G U I D A N C E Guidance on the Biocidal Products Regulation Volume V, Guidance on active substances and suppliers (Article 95 list) Version 2.1 March 2017 2 Guidance on BPR: Volume V Version 2.1 March

More information

Reflection Paper on Medicinal Product Supply Shortages Caused by Manufacturing/GMP Compliance Problems. Outcome of 10 September 2012 Workshop

Reflection Paper on Medicinal Product Supply Shortages Caused by Manufacturing/GMP Compliance Problems. Outcome of 10 September 2012 Workshop Reflection Paper on Medicinal Product Supply Shortages Caused by Manufacturing/GMP Compliance Problems Outcome of 10 September 2012 Workshop Management Board Meeting - Agenda Point B10 04 October 2012

More information

Do you know the requirements and your responsibilities for medical device vigilance reporting?

Do you know the requirements and your responsibilities for medical device vigilance reporting? Do you know the requirements and your responsibilities for medical device vigilance ing? A detailed review on the requirements of MDSAP participating countries in comparison with the European Medical Device

More information

APPENDIX 11 REPRODUCTIVE AND DEVELOPMENTAL HEALTH POLICY

APPENDIX 11 REPRODUCTIVE AND DEVELOPMENTAL HEALTH POLICY APPENDIX 11 REPRODUCTIVE AND DEVELOPMENTAL HEALTH POLICY Chemical Hygiene Guide October 2009 Appendix 11-1- Chemical Hygiene Guide October 2009 Appendix 11-2- Reproductive and Developmental Health Policy

More information

Guideline on good pharmacovigilance practices (GVP)

Guideline on good pharmacovigilance practices (GVP) 9 October 2017 2017 EMA/118465/2012 Rev 1* Guideline on good pharmacovigilance practices (GVP) Module XV Safety communication (Rev 1) Date for coming into effect of first version 24 January 2013 Draft

More information

H2020 FOF Innovation Action GUIDE FOR APPLICANTS. HORSE Application Experiments

H2020 FOF Innovation Action GUIDE FOR APPLICANTS. HORSE Application Experiments H2020 FOF 09 2015 Innovation Action GUIDE FOR APPLICANTS Table of contents 1 GENERAL INFORMATION... 2 2 EXPECTED CONTRIBUTIONS AND IMPACT... 3 3 ACTIVITIES, ELIGIBILITY AND FUNDING... 3 4 PROPOSAL SUBMISSION...

More information

Safeguarding public health. The New PV Legislation its Impact on PV & MI

Safeguarding public health. The New PV Legislation its Impact on PV & MI Safeguarding public health The New PV Legislation its Impact on PV & MI Sarah Vaughan - MHRA PIPA 2013 Manager s Meeting 13 th February 2013 Content Scope of change Key areas - ADR reporting - DDPS to

More information

Vienna. The New EU Regulation 2017/745 on Medical Devices. Tuesday 26 and Wednesday 27 June and 27 June Vienna.

Vienna. The New EU Regulation 2017/745 on Medical Devices. Tuesday 26 and Wednesday 27 June and 27 June Vienna. Understanding the Regulation and its impact on Industry Course Language: English 210 Early Bird discount for enrolment by 30 th May 2018 Vienna Austria Tuesday 26 and Wednesday 27 June 2018 09:00-17:00

More information

CHEMICALS (Classification, Labelling, Packaging of substances and mixtures -CLP) Screening Meeting EU Serbia June 2013

CHEMICALS (Classification, Labelling, Packaging of substances and mixtures -CLP) Screening Meeting EU Serbia June 2013 CHEMICALS (Classification, Labelling, Packaging of substances and mixtures -CLP) Screening Meeting EU Serbia June 2013 Regulation (EC) No 1272/2008 on classification, labelling and packaging of substances

More information

Toolbox for the collection and use of OSH data

Toolbox for the collection and use of OSH data 20% 20% 20% 20% 20% 45% 71% 57% 24% 37% 42% 23% 16% 11% 8% 50% 62% 54% 67% 73% 25% 100% 0% 13% 31% 45% 77% 50% 70% 30% 42% 23% 16% 11% 8% Toolbox for the collection and use of OSH data 70% These documents

More information

CLP the implementation of GHS in the EU Facts and practical advice

CLP the implementation of GHS in the EU Facts and practical advice CLP the implementation of GHS in the EU Facts and practical advice Seminar on the latest trend regarding revised CSCL, REACH and CLP 30 March 2010, Tokyo Gabriele Schöning ECHA Classification Unit Content

More information

Update of the Work plan on international activities 2012

Update of the Work plan on international activities 2012 Helsinki, 15 December 2011 Doc.: MB/57/2011 final Update of the Work plan on international activities 2012 (Document endorsed by the Management Board) WORK PLAN FOR INTERNATIONAL ACTIVITIES OF ECHA 2012

More information

Guidance for the conduct of good clinical practice inspections

Guidance for the conduct of good clinical practice inspections 23 August 2017 EMA/839541/2015 Guidance for the conduct of good clinical practice inspections Adopted by GCP Inspectors Working Group (GCP IWG) 4 September 2017 Keywords Conduct of GCP inspections 30 Churchill

More information

EFSA: mission and tasks, strategic perspectives and cooperation activities

EFSA: mission and tasks, strategic perspectives and cooperation activities EFSA: mission and tasks, strategic perspectives and cooperation activities Hans Verhagen, Head of Risk Assessment and Scientific Assistance Department EFSA S MISSION Contribute to the safety of the EU

More information

Governance for the Many Uses of EHR Data

Governance for the Many Uses of EHR Data Governance for the Many Uses of EHR Data Dr. Päivi Hämäläinen, National Institute for Health and Welfare THL, Finland 16.3.2017 Dr. Päivi Hämäläinen 1 Many users, two+ cases 1. Primary use of patient data;

More information

COMMERCIALISATION FUND PROGRAMME Reference Document

COMMERCIALISATION FUND PROGRAMME Reference Document COMMERCIALISATION FUND PROGRAMME Reference Document PROGRAMME OVERVIEW The aim of the Commercialisation Fund programme is to improve the competitiveness of the Irish economy through the creation of technology

More information

MINIMUM CRITERIA FOR REACH AND CLP INSPECTIONS 1

MINIMUM CRITERIA FOR REACH AND CLP INSPECTIONS 1 FORUM FOR EXCHANGE OF INFORMATION ON ENFORCEMENT Adopted at the 9 th meeting of the Forum on 1-3 March 2011 MINIMUM CRITERIA FOR REACH AND CLP INSPECTIONS 1 MARCH 2011 1 First edition adopted at the 6

More information

Decontamination of Medical Devices:

Decontamination of Medical Devices: Decontamination of Medical Devices: a development plan for healthcare organisations January 2016 Crown copyright 2016 WG27312 Digital ISBN 978 1 4734 5431 6 Foreword Eliminating preventable healthcare

More information

Preparation of the final technical report

Preparation of the final technical report Preparation of the final technical report Jurgita Kaminskaite, project officer Consumers, health, agriculture and food executive agency (Chafea), European Commission 7 December 2015 Final report 2 Outline

More information

abcdefghijklmnopqrstu

abcdefghijklmnopqrstu Healthcare Policy and Strategy Directorate Quality Division Dear Colleague INTRODUCTION AND AVAILABILITY OF NEWLY LICENSED MEDICINES IN THE NHS IN SCOTLAND Dear Colleague This guidance sets out the policy

More information

UK strategy for reclassification of medicines. Dr Sarah Branch, Deputy Director, VRMM Division

UK strategy for reclassification of medicines. Dr Sarah Branch, Deputy Director, VRMM Division UK strategy for reclassification of medicines Dr Sarah Branch, Deputy Director, VRMM Division MHRA commitment to reclassification Reclassification of medicines to non-prescription when safe to do so and

More information

Post Market Surveillance and Vigilance in Japan. Medical Device Safety Division, Office of Safety I

Post Market Surveillance and Vigilance in Japan. Medical Device Safety Division, Office of Safety I Post Market Surveillance and Vigilance in Japan Medical Device Safety Division, Office of Safety I 1 Overview of Adverse Event Reporting 医療機関 Healthcare professionals /facilities 2. Investigation 3. Investigation

More information

Good Pharmacovigilance Practice. Overview of GVP Modules on ADR, PSURs, Signal Management and Additional Monitoring Mick Foy - MHRA

Good Pharmacovigilance Practice. Overview of GVP Modules on ADR, PSURs, Signal Management and Additional Monitoring Mick Foy - MHRA Good Pharmacovigilance Practice Overview of GVP Modules on ADR, PSURs, Signal Management and Additional Monitoring Mick Foy - MHRA Content ADR Reporting Definition & Increased scope Transition arrangements

More information

https://helsedirektoratet.no/english Regulatory and ethics bodies involved in approval process

https://helsedirektoratet.no/english Regulatory and ethics bodies involved in approval process Medical Devices - NORWAY Competent authority Contact Details Contact Name 1 Norwegian Directorate of Health Email Department medisinsk.utstyr@ helsedir.no Address PO Box 7000; St. Olavs plass ZIP/City

More information

Accomplish, achieve and learn in a supportive environment while contributing to the protection of public and animal health

Accomplish, achieve and learn in a supportive environment while contributing to the protection of public and animal health Graduate Programme Accomplish, achieve and learn in a supportive environment while contributing to the protection of public and animal health www.hpra.ie HPRA GRADUATE PROGRAMME Our Graduate Programme

More information

Proposal for a new legal framework for data protection in EU

Proposal for a new legal framework for data protection in EU Proposal for a new legal framework for data protection in EU ENCePP Plenary Meeting 3 May 2012 Alessandro SPINA - EMA Data Protection Officer An agency of the European Union Background/1 In EU, legislation

More information

EUCERD RECOMMENDATIONS on RARE DISEASE EUROPEAN REFERENCE NETWORKS (RD ERNS)

EUCERD RECOMMENDATIONS on RARE DISEASE EUROPEAN REFERENCE NETWORKS (RD ERNS) EUCERD RECOMMENDATIONS on RARE DISEASE EUROPEAN REFERENCE NETWORKS (RD ERNS) 31 January 2013 1 EUCERD RECOMMENDATIONS ON RARE DISEASE EUROPEAN REFERENCE NETWORKS (RD ERNS) INTRODUCTION 1. BACKGROUND TO

More information

Food Hygiene Rating Scheme A Report for the National Assembly of Wales

Food Hygiene Rating Scheme A Report for the National Assembly of Wales Food Hygiene Rating Scheme A Report for the National Assembly of Wales Review of the Implementation and Operation of the Statutory Food Hygiene Rating Scheme and the Operation of the Appeals System in

More information

Regulating medical education and professions

Regulating medical education and professions November 4, 2016 Overview Problem statement Present arrangement NITI Aayog (NITI) draft law Strategies for reform Proposed design Part I Problem Statement Ninety-Second Report on the Functioning of the

More information

AUDIT REPORT. Audit of Official Controls carried out by the Health Service Executive (Regulation (EC) No 853/2004)

AUDIT REPORT. Audit of Official Controls carried out by the Health Service Executive (Regulation (EC) No 853/2004) AUDIT REPORT Audit of Official Controls carried out by the Health Service Executive (Regulation (EC) No 853/2004) AUDIT REPORT Audit of Official Controls carried out by the Health Service Executive (Regulation

More information

Psychosocial risks and violence at work: prevalence and prevention approaches in Europe

Psychosocial risks and violence at work: prevalence and prevention approaches in Europe Psychosocial risks and violence at work: prevalence and prevention approaches in Europe A+A ILO International Occupational Safety and Health Conference 2017 18-19 October 2017, Dusseldorf Malgorzata Milczarek,

More information

"ERA-NET Plus Actions"

ERA-NET Plus Actions "ERA-NET Plus Actions" PROVISIONS FOR THE PREPARATION OF ERA-NET PLUS ACTIONS AND THEIR PRACTICAL IMPLEMENTATION A draft issue paper serving as background document 1 RTD B.1 Coordination of national research

More information